These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 30980486)

  • 21. Effect of resection margin status on recurrence pattern and survival in distal pancreatectomy for left-sided pancreatic ductal adenocarcinoma.
    Kwon J; Lee SR; Park SY; Lee JH; Song KB; Hwang DW; Shin JH; Kim SC
    J Hepatobiliary Pancreat Sci; 2023 May; 30(5):633-643. PubMed ID: 36380718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified Appleby procedure for borderline resectable/locally advanced distal pancreatic adenocarcinoma: A major procedure for selected patients.
    Cesaretti M; Abdel-Rehim M; Barbier L; Dokmak S; Hammel P; Sauvanet A
    J Visc Surg; 2016 Jun; 153(3):173-81. PubMed ID: 26775202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic distal pancreatectomy for pancreatic cancer is safe and effective.
    Bauman MD; Becerra DG; Kilbane EM; Zyromski NJ; Schmidt CM; Pitt HA; Nakeeb A; House MG; Ceppa EP
    Surg Endosc; 2018 Jan; 32(1):53-61. PubMed ID: 28643065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate?
    Kooby DA; Hawkins WG; Schmidt CM; Weber SM; Bentrem DJ; Gillespie TW; Sellers JB; Merchant NB; Scoggins CR; Martin RC; Kim HJ; Ahmad S; Cho CS; Parikh AA; Chu CK; Hamilton NA; Doyle CJ; Pinchot S; Hayman A; McClaine R; Nakeeb A; Staley CA; McMasters KM; Lillemoe KD
    J Am Coll Surg; 2010 May; 210(5):779-85, 786-7. PubMed ID: 20421049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: results of a multicenter cohort study on 196 patients.
    Sahakyan MA; Kazaryan AM; Rawashdeh M; Fuks D; Shmavonyan M; Haugvik SP; Labori KJ; Buanes T; Røsok BI; Ignjatovic D; Abu Hilal M; Gayet B; Kim SC; Edwin B
    Surg Endosc; 2016 Aug; 30(8):3409-18. PubMed ID: 26514135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diversity between curatively resected pancreatic head and body-tail cancers based on the 8th edition of AJCC staging system: a multicenter cohort study.
    Sheng W; Dong M; Wang G; Shi X; Gao W; Wang K; Song H; Shi G; Tan X
    BMC Cancer; 2019 Oct; 19(1):981. PubMed ID: 31640615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between the tumor location and clinicopathological features in left-sided pancreatic ductal adenocarcinoma.
    Hirashita T; Iwashita Y; Fujinaga A; Nakanuma H; Masuda T; Endo Y; Ohta M; Inomata M
    Surg Today; 2021 May; 51(5):814-820. PubMed ID: 32970195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas.
    Fukumoto T; Watanabe T; Hirai I; Kimura W
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):472-9. PubMed ID: 27246905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative oncologic impact of poor postoperative pain control in left-sided pancreatic cancer.
    Min EK; Chong JU; Hwang HK; Pae SJ; Kang CM; Lee WJ
    World J Gastroenterol; 2017 Jan; 23(4):676-686. PubMed ID: 28216975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: Long-term oncologic outcomes after standard resection.
    Sahakyan MA; Kim SC; Kleive D; Kazaryan AM; Song KB; Ignjatovic D; Buanes T; Røsok BI; Labori KJ; Edwin B
    Surgery; 2017 Oct; 162(4):802-811. PubMed ID: 28756944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes after preoperative endoscopic ultrasonography and biopsy in patients undergoing distal pancreatectomy.
    Beane JD; House MG; Coté GA; DeWitt JM; Al-Haddad M; LeBlanc JK; McHenry L; Sherman S; Schmidt CM; Zyromski NJ; Nakeeb A; Pitt HA; Lillemoe KD
    Surgery; 2011 Oct; 150(4):844-53. PubMed ID: 22000199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal adenocarcinoma.
    Li TJ; Li H; Zhang WH; Xu SS; Jiang W; Li S; Gao HL; Han X; Xu HX; Wu CT; Wang WQ; Yu XJ; Liu L
    Int J Cancer; 2021 Apr; 148(7):1756-1767. PubMed ID: 33236361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Multicenter Study.
    Sakamoto T; Gocho T; Tsunematsu M; Shirai Y; Hamura R; Haruki K; Abe K; Okamoto T; Shiozaki H; Fujioka S; Iwase R; Kumagai YU; Usuba T; Ikegami T
    Anticancer Res; 2023 Jan; 43(1):201-208. PubMed ID: 36585157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of preoperative total lymphocyte count with prognosis in resected left-sided pancreatic cancer.
    Rho SY; Hwang HK; Chong JU; Yoon DS; Lee WJ; Kang CM
    ANZ J Surg; 2019 May; 89(5):503-508. PubMed ID: 30836428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
    Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
    Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.
    Morales-Oyarvide V; Rubinson DA; Dunne RF; Kozak MM; Bui JL; Yuan C; Qian ZR; Babic A; Da Silva A; Nowak JA; Khalaf N; Brais LK; Welch MW; Zellers CL; Ng K; Chang DT; Miksad RA; Bullock AJ; Tseng JF; Swanson RS; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Hornick JL; Ogino S; Fuchs CS; Hezel AF; Koong AC; Wolpin BM
    Br J Cancer; 2017 Dec; 117(12):1874-1882. PubMed ID: 28982112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas.
    Christein JD; Kendrick ML; Iqbal CW; Nagorney DM; Farnell MB
    J Gastrointest Surg; 2005; 9(7):922-7. PubMed ID: 16137585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LDP vs ODP for pancreatic adenocarcinoma: a case matched study from a single-institution.
    Zhang M; Fang R; Mou Y; Chen R; Xu X; Zhang R; Yan J; Jin W; Ajoodhea H
    BMC Gastroenterol; 2015 Dec; 15():182. PubMed ID: 26695506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma.
    Li G; Chen JZ; Chen S; Lin SZ; Pan W; Meng ZW; Cai XR; Chen YL
    Cancer Med; 2020 May; 9(10):3353-3370. PubMed ID: 32181599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.